Delivery Order SPE2DE24DA017-SPE2D626F059D
- Not listed
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,250.00 for the Arthrex ACP Double Syringe System on September 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion on September 18, 2025, and will be performed at the company's Naples, FL facility. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,665.20 for the Arthrex ACP Double Syringe System on April 24, 2025. This fixed-price contract with economic price adjustment carries an ultimate completion date of April 29, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain to support the government's orthopedic medical device needs,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $4,950 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain on November 7, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries an ultimate completion date of November 13, 2025. This award was issued without a set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,618.96 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by July 23, 2025, and will be performed in Naples, FL. This award was issued without a set-aside designation, reflecting Arthrex's strong competitive...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $13,867.20 on September 22, 2025, for an ACP Kit Series I, with an ultimate completion date of September 25, 2025. This fixed-price contract with economic price adjustment is being funded by the Defense Logistics Agency's Medical Supply Chain and will be performed in Naples, Florida. The award utilizes no set-aside designation, reflecting Arthrex's competitive standing in the federal orthopedic medical...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $9,900 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment was issued on September 3, 2025, with an ultimate completion date of September 17, 2025. The award represents a non-set-aside competitive procurement and will be...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F059DDelivery Order
Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $1,650 on November 7, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment has an ultimate completion date of November 13, 2025, and will be performed at the contractor's Naples, Florida location. The award was made without a set-aside designation, reflecting Arthrex's strong competitive position in federal procurement. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, which supports orthopedic surgical needs across the Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued under Arthrex's existing single-award Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at approximately $471 million and effective through September 1, 2029. Arthrex serves as the prime contractor with no identified subcontractors, delivering a comprehensive portfolio of minimally invasive orthopedic medical technologies and surgical instruments to support military personnel and veterans. The master contract vehicle has already generated over $550,000 in delivery order activity across multiple Veterans Integrated Service Networks, enabling efficient procurement of advanced orthopedic solutions for joint replacement, arthroscopic procedures, and specialized surgical applications across multiple orthopedic specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/7/25 |